Health Canada says it’s delaying the implementation of long-awaited changes to Canada’s drug-pricing regime by another six months. A spokesman for the department, says the amendments to patented medicine regulations, which were set to take effect Jan. 1, will now come into force on July 1. Geoffroy Legault-Thivierge says the postponement is intended to give pharmaceutical manufacturers […]
With drug costs for plan sponsors steadily rising in recent years, keeping budgets down is top of mind as they plan for 2021. “The biggest concern for plan sponsors is sustainability,” said Shawn O’Brien, principal of data enablement and drug, health, dental product roadmap for Telus Health, in a press release. “They have to find a […]
When the City of Toronto switched benefits plan insurers in 2017, it changed its coverage for biologics and biosimilars. Under its previous plan, the City reimbursed employees for the drugs their doctors recommended and prescribed; now, it follows its new insurer’s mandatory biosimilars policy, while grandfathering any plan member who was already taking a biologic […]
The coronavirus pandemic has significantly increased plan members’ willingness to seek help for their mental-health concerns and to access video or telephone counselling, said Julie Gaudry, senior director of group insurance for RBC Insurance, during Benefits Canada’s 2020 Mental Health Summit on Nov. 12. An RBC Insurance survey of plan members found two-thirds (67 per cent) […]
Defining depression may seem simple, but it’s actually a complex mental-health disorder that can look different for every person it affects. That’s why a personalized treatment plan is crucial to alleviate symptoms and promote recovery, said Dr. Diane McIntosh, psychiatrist and chief neuroscience officer at Telus Health, during a session at Benefit Canada’s 2020 Mental Health […]
Telus Health is partnering with Canada Life Assurance Co. and Innomar Strategies Inc. to launch Canada’s an electronic drug prior authorization solution. The pilot program will test the digitized process to fulfill prior authorization submissions for real prescription cases and evaluate its impact on process efficiency, consistency of adjudication results and the overall plan sponsor and member […]
The costs of employer-provided health plans in Canada are expected to rise seven per cent next year, outpacing general inflation by more than five per cent, according to a new report by Aon Canada. Contributing factors include higher drug prices, the impact of non-communicable health risks and the continued introduction of new and expensive therapies. Indeed, […]
In its 2020 budget submission to the Ontario government, the Canadian Life and Health Insurance Association is highlighting a lack of access to affordable prescription drugs and inflexible pension plans. With respect to prescription drugs, the CLHIA noted it supports the federal Patented Medicine Prices Review Board reforms, which were introduced on Friday. “It is crucial that the […]
The Patented Medicine Prices Review Board published its new guidelines on Friday. The guidelines, which will take effect on Jan. 1, 2021, aim to modernize Canada’s pricing framework for patented medicines. They explain the steps that will typically be taken by the PMPRB’s staff in assessing whether a patented medicine appears to be priced excessively in Canada. The […]
While medical cannabis coverage is appearing in more benefits plans, most insurers that cover it still have very specific conditions. Sun Life Canada covers the most conditions, at seven, after adding two ailments to its roster in 2019. Marie-Chantal Côté, the insurer’s vice-president of market development for group benefits, says evidence is emerging that shows […]